4LC9

Structural Basis for Regulation of Human Glucokinase by Glucokinase Regulatory Protein

Summary for 4LC9

• Entry DOI: 10.2210/pdb4lc9/pdb
• Related: 1V4S 1V4T
• Descriptor: Glucokinase regulatory protein, Glucokinase, 6-O-phosphono-beta-D-fructofuranose, ... (4 entities in total)
• Functional Keywords: type 2 diabetes, transferase-transferase regulator complex, transferase/transferase regulator
• Biological source: Rattus norvegicus (brown rat,rat,rats); More
• Total number of polymer chains: 2
• Total formula weight: 123640.04

Authors

Beck, T.,Miller, B.G. (deposition date: 2013-06-21, release date: 2013-09-04, Last modification date: 2024-02-28)

Primary citation

Beck, T.,Miller, B.G.
Structural basis for regulation of human glucokinase by glucokinase regulatory protein.
Biochemistry, 52:6232-6239, 2013

PubMed Abstract: Glucokinase (GCK) is responsible for maintaining glucose homeostasis in the human body. Dysfunction or misregulation of GCK causes hyperinsulinemia, hypertriglyceridemia, and type 2 diabetes. In the liver, GCK is regulated by interaction with the glucokinase regulatory protein (GKRP), a 68 kDa polypeptide that functions as a competitive inhibitor of glucose binding to GCK. Formation of the mammalian GCK-GKRP complex is stimulated by fructose 6-phosphate and antagonized by fructose 1-phosphate. Here we report the crystal structure of the mammalian GCK-GKRP complex in the presence of fructose 6-phosphate at a resolution of 3.50 Å. The interaction interface, which totals 2060 Å(2) of buried surface area, is characterized by a small number of polar contacts and substantial hydrophobic interactions. The structure of the complex reveals the molecular basis of disease states associated with impaired regulation of GCK by GKRP. It also offers insight into the modulation of complex stability by sugar phosphates. The atomic description of the mammalian GCK-GKRP complex provides a framework for the development of novel diabetes therapeutic agents that disrupt this critical macromolecular regulatory unit.

PubMed: 23957911
DOI: 10.1021/bi400838t

Experimental method

X-RAY DIFFRACTION (3.4 Å)